Luca Boldrini: MRI-Guided Stereotactic Radiotherapy for Oligometastatic Peritoneal Carcinomatosis
Luca Boldrini, Chair of the ESTRO Education Council EDC, posted on LinkedIn:
“Have a look to our latest paper:
Hot off the press in Springer Nature “Clinical and Experimental Metastasis” journal.
Thanks to Angela Romano for coordinating this great teamwork of the Gemelli, ART ViewRay Systems, MRI guided unit and to all the Fondazione Policlinico Universitario Agostino Gemelli IRCCS RT department.
MRI‑guided SBRT (MRIgSBRT) witH online adaptive planning in real time for target and anatomy shifts is a game changer clinical benefit (CR + PR + SD): 84.3%, 2‑years local control: 82%. Zero acute or late toxicities.”
Authors: Angela Romano, Giuditta Chiloiro, Luca Boldrini, Giulia Panza, Ilaria Castanò, Maura Campitelli, Isabella Costamagna, Irene Moretti, Matteo Nardini, Marco Valerio Antonelli, Claudio Votta, Lorenzo Placidi & Maria Antonietta Gambacorta
Further Reading: Radiotherapy for Rectal Cancer: Types, Success Rate, Side Effects And More
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023